|Title||Identification and monitoring of metabolite markers of dry bean consumption in parallel human and mouse studies.|
|Publication Type||Journal Article|
|Year of Publication||2015|
|Authors||Perera T, Young MR, Zhang Z, Murphy G, Colburn NH, Lanza E, Hartman TJ, Cross AJ, Bobe G|
|Journal||Mol Nutr Food Res|
|Date Published||2015 Apr|
|Keywords||Adult, Aged, Animals, Anticarcinogenic Agents, Biomarkers, Chromatography, Liquid, Colorectal Neoplasms, Cross-Over Studies, Cysteine, Diet, Fabaceae, Feces, Gastrointestinal Microbiome, Humans, Intestinal Mucosa, Intestines, Male, Mass Spectrometry, Metabolomics, Mice, Mice, Inbred Strains, Middle Aged, Pipecolic Acids, Plant Extracts|
SCOPE: Aim of the study was to identify and monitor metabolite markers of dry bean consumption in parallel human and mouse studies that each had shown chemopreventive effects of dry bean consumption on colorectal neoplasia risk.
METHODS AND RESULTS: Using LC/mass spectroscopy ± ESI and GC/mass spectroscopy, serum metabolites of dry beans were measured in 46 men before and after a 4-week dry bean enriched diet (250 g/day) and 12 mice that received a standardized diet containing either 0 or 10% navy bean ethanol extract for 6 weeks; we also investigated fecal metabolites in the mice. The serum metabolites identified in these controlled feeding studies were then investigated in 212 polyp-free participants from the Polyp Prevention Trial who self-reported either increased (≥+31 g/day from baseline), high dry bean intake of ≥42 g/day in year 3 or low, unchanged dry bean consumption of <8 g/day; serum was analyzed from baseline and year 3. Serum pipecolic acid and S-methyl cysteine were elevated after dry bean consumption in human and mouse studies and reflected dry bean consumption in the Polyp Prevention Trial.
CONCLUSION: Serum levels of pipecolic acid and S-methyl cysteine are useful biomarkers of dry bean consumption.
|Alternate Journal||Mol Nutr Food Res|
|PubMed Central ID||PMC4417744|
|Grant List||M01 RR010732 / RR / NCRR NIH HHS / United States |
ZIA BC010025 / BC / NCI NIH HHS / United States
M01 RR10732 / RR / NCRR NIH HHS / United States
Z01 CP010198 / CP / NCI NIH HHS / United States
/ / Intramural NIH HHS / United States
Z01 CP10198-08 / CP / NCI NIH HHS / United States
OD000008-007 / OD / NIH HHS / United States